TY - JOUR
T1 - Microstructures, mechanical properties and cytotoxicity of low cost beta Ti-Mn alloys for biomedical applications
AU - Santos, Pedro Fernandes
AU - Niinomi, Mitsuo
AU - Cho, Ken
AU - Nakai, Masaaki
AU - Liu, Huihong
AU - Ohtsu, Naofumi
AU - Hirano, Mitsuhiro
AU - Ikeda, Masahiko
AU - Narushima, Takayuki
N1 - Funding Information:
This study was supported in part by a Grant-in-Aid for Scientific Research (A) No. 24246111 and a Grant-in-Aid for Young Scientists (B) No. 25820367 from the Japan Society for the Promotion of Science ( JSPS ), the Inter-University Cooperative Research Program “Innovation Research for Biosis-Abiosis Intelligent Interface” from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and Inamori Grants from the Inamori Foundation , Japan.
Publisher Copyright:
© 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
PY - 2015/10/15
Y1 - 2015/10/15
N2 - The microstructures, mechanical properties and biocompatibility of low cost β-type Ti-(6-18)Mn alloys were investigated after solution treatment. Ti-9Mn exhibits the best combination of tensile strength and elongation among the fabricated alloys, and its performance is comparable to or superior to those of Ti-6Al-4V ELI (Ti-64 ELI) in terms of every parameter evaluated. A hardness of 338 HV, a Young's modulus of 94 GPa, a 0.2% proof stress of 1023 MPa, an ultimate tensile strength of 1048 MPa and elongation of 19% were obtained for Ti-9Mn. Furthermore, the cell viability and metallic ion release ratios are comparable to those of commercially pure titanium, making this alloy promising for biomedical applications. The Young's modulus is also lower than that of Ti-64 ELI (110 GPa), which can possibly reduce the stress shielding effect in implanted patients. Statement of significance This study evaluates mechanical and biological performance of low cost solution treated β-type Ti-(6, 9, 13 and 18 mass%)Mn alloys. It includes alloys containing a Mn content range higher than most previously published works (which is around or lower than 8 mass%). Furthermore, the effects of the ω phase and the β phase stability of the alloys over some mechanical properties and microstructures are discussed. Ion release behavior under simulated body fluids and cell viability are also evaluated. For the case of the Ti-9Mn, a mechanical and biological performance that is comparable to or superior than that of the widely used Ti-6Al-4V ELI and commercially pure Ti was observed.
AB - The microstructures, mechanical properties and biocompatibility of low cost β-type Ti-(6-18)Mn alloys were investigated after solution treatment. Ti-9Mn exhibits the best combination of tensile strength and elongation among the fabricated alloys, and its performance is comparable to or superior to those of Ti-6Al-4V ELI (Ti-64 ELI) in terms of every parameter evaluated. A hardness of 338 HV, a Young's modulus of 94 GPa, a 0.2% proof stress of 1023 MPa, an ultimate tensile strength of 1048 MPa and elongation of 19% were obtained for Ti-9Mn. Furthermore, the cell viability and metallic ion release ratios are comparable to those of commercially pure titanium, making this alloy promising for biomedical applications. The Young's modulus is also lower than that of Ti-64 ELI (110 GPa), which can possibly reduce the stress shielding effect in implanted patients. Statement of significance This study evaluates mechanical and biological performance of low cost solution treated β-type Ti-(6, 9, 13 and 18 mass%)Mn alloys. It includes alloys containing a Mn content range higher than most previously published works (which is around or lower than 8 mass%). Furthermore, the effects of the ω phase and the β phase stability of the alloys over some mechanical properties and microstructures are discussed. Ion release behavior under simulated body fluids and cell viability are also evaluated. For the case of the Ti-9Mn, a mechanical and biological performance that is comparable to or superior than that of the widely used Ti-6Al-4V ELI and commercially pure Ti was observed.
KW - Biocompatibility
KW - Low cost Ti alloy
KW - Mechanical properties
KW - Ti-Mn alloys
KW - β phase
UR - http://www.scopus.com/inward/record.url?scp=84942294837&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942294837&partnerID=8YFLogxK
U2 - 10.1016/j.actbio.2015.08.015
DO - 10.1016/j.actbio.2015.08.015
M3 - Article
C2 - 26283166
AN - SCOPUS:84942294837
SN - 1742-7061
VL - 26
SP - 366
EP - 376
JO - Acta Biomaterialia
JF - Acta Biomaterialia
ER -